The war on cryptococcosis: A Review of the antifungal arsenal

The relentless march of cryptococcal meningitis

(2017) Peter R Williamson   LANCET INFECTIOUS DISEASES

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

(2017) Radha Rajasingham et al.   LANCET INFECTIOUS DISEASES

The antifungal pipeline: a reality check

(2017) John R. Perfect   NATURE REVIEWS DRUG DISCOVERY

Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults

(2016) Anil A. Panackal et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: Life-saving Antimicrobial Drugs: What Are We Doing to Pricing and Availability?

(2016) John R. Perfect   CLINICAL INFECTIOUS DISEASES

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

(2016) George R. Thompson et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

(2016) Joshua Rhein et al.   LANCET INFECTIOUS DISEASES

Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy

(2016) Peter R. Williamson et al.   Nature Reviews Neurology

Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis

(2016) Justin Beardsley et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Therapeutic Approach for Cryptococcal Meningitis

(2016) Drew Cutshaw et al.   Open Forum Infectious Diseases

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis

(2015) Tihana Bicanic et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study

(2015) Nicky Longley et al.   CLINICAL INFECTIOUS DISEASES

Cryptococcal Antigen Screening and Early Antifungal Treatment to Prevent Cryptococcal Meningitis

(2015) Jonathan E. Kaplan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Voriconazole: a novel treatment option for cryptococcal meningitis

(2015) Yan Yao et al.   Infectious Diseases

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality

(2015) Emilio Letang et al.   Open Forum Infectious Diseases

Prevalence, Correlates, and Outcomes of Cryptococcal Antigen Positivity Among Patients With AIDS, United States, 1986–2012

(2014) Jennie McKenney et al.   CLINICAL INFECTIOUS DISEASES

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis

(2014) Melissa A. Rolfes et al.   CLINICAL INFECTIOUS DISEASES

Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis

(2014) David R. Boulware et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Prospective Study of Mortality from Cryptococcal Meningitis following Treatment Induction with 1200mg Oral Fluconazole in Blantyre, Malawi

(2014) Katherine M. Gaskell et al.   PLoS One

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus gattii in Otherwise Immunocompetent Patients

(2014) T. Saijo et al.   mBio

Cryptococcal meningitis: epidemiology and therapeutic options

(2014) Derek Sloan et al.   Clinical Epidemiology

Point-of-Care Diagnosis and Prognostication of Cryptococcal Meningitis With the Cryptococcal Antigen Lateral Flow Assay on Cerebrospinal Fluid

(2013) Taseera Kabanda et al.   CLINICAL INFECTIOUS DISEASES

Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis

(2013) Richard Ssekitoleko et al.   Future Virology

Combination Antifungal Therapy for Cryptococcal Meningitis

(2013) Jeremy N. Day et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

(2012) Joseph N. Jarvis et al.   AIDS

Immunotherapy of Cryptococcus infections

(2011) C. Antachopoulos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and Safety

(2010) Richard J. Hamill et al.   CLINICAL INFECTIOUS DISEASES

Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings

(2010) David B. Meya et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV‐Associated Cryptococcal Meningitis

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi

(2009) Jesse C. Nussbaum et al.   CLINICAL INFECTIOUS DISEASES

Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

(2009) Andrew R. Zolopa et al.   PLoS One

High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial

(2008) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis

(2008) Eric Milefchik et al.   MEDICAL MYCOLOGY

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis

(2008) Françoise Dromer et al.   PLoS One